In all categories for both US and non-US , the survival outcomes have improved over time.
The majority of US cases in 1994-1998 were SPK (86%); PAK accounted for 9% and PTA for 4% (Figure 2).
The majority of all non-US pancreas transplants were SPK (92%), then PAK (4%) and PTA (4%) (Text only).
Figure 2
Previous Page / Next Page / Index Page